Key result
Warfarin-related nephropathy occurred in 19.3% of patients with excessive warfarinization and significantly increased long-term mortality compared to those without WRN (42.8% vs 26.3%, p<0.001).
Why the study?
What is the incidence, risk factors, and clinical impact of warfarin-related nephropathy in Korean patients with excessive warfarinization?
Cohort (n=1,297)
No
What is the incidence, risk factors, and clinical impact of warfarin-related nephropathy in Korean patients with excessive warfarinization?
Absolute Event Rate: 42.8% vs 26.3%
p-value: p=<0.001
Warfarin-related nephropathy occurs in nearly 20% of Korean patients with excessive warfarinization and is associated with sustained renal impairment and increased long-term mortality.
Warfarin-related nephropathy was associated with higher mortality in Korean patients; leaves open whether monitoring or prevention alters outcomes.
BACKGROUND: Warfarin-related nephropathy (WRN) is a recently described disease entity, in which excessive warfarinization (international normalized ratio (INR) >3.0) causes acute kidney injury. Previous reports regarding WRN included few Asian patients who might have differed from the western WRN patients in terms of genetic and environmental factors. METHODS: During the period of March 2003 to December 2011, the data about a total of 1297 patients who had serum creatinine (sCr) level measured within 1 week after INR >3.0 and within 6 months before INR >3.0 was analyzed through the retrospective review of electronic medical records of a single tertiary hospital in Korea. RESULT: WRN developed in 19.3% of patients having excessive warfarinization. The incidence was higher in the chronic kidney disease (CKD) group than the non-CKD group. The risk of WRN increased as the basal serum albumin level decreased and was strongly associated with highest quartile serum AST level at post INR elevation and the presence of congestive heart failure. But the presence of atrial fibrillation was protective against the development of WRN. Neither the presence of CKD nor basal estimated glomerular filtration rate (eGFR) was an independent risk factor for WRN. Despite no difference in the basal sCr level, the sCr level was higher in patients with WRN than those without WRN after follow-up. The mortality rates were also higher in patients with WRN. CONCLUSIONS: WRN developed in 19.3% of patients having excessive warfarinization. A lower basal serum albumin, highest quartile serum AST level at post INR elevation, and congestive heart failure were associated with the occurrence of WRN. The development of WRN adversely affected renal and patient outcomes.
No takes yet. Share an insight, caveat, or question.
An et al. (2013) conducted a cohort in Excessive warfarinization (n=1,297). Warfarin-related nephropathy (WRN) vs. No WRN was evaluated on Long-term mortality (p=<0.001). Warfarin-related nephropathy occurred in 19.3% of patients with excessive warfarinization and significantly increased long-term mortality compared to those without WRN (42.8% vs 26.3%, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: